Grade 2 Astrocytoma — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for grade 2 astrocytoma. 10 active patents protecting 1 drugs from 1+ originators. First major cliff: 2034. Daily refresh.

1
Approved drugs
10
Active US patents
52/100
Avg vulnerability
—
Annual revenue covered

Originators in Grade 2 Astrocytoma

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Servier 10 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating grade 2 astrocytoma. Each bar = one year. Y-axis scaled to peak year (6 patents).

6
34
2
35
2
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Voranigo
VORASIDENIB
 Servier 10 52 — 2034-07-11

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12433895 Voranigo method of use 75 2034-07-11
12433895 Voranigo method of use 75 2034-07-11
11844758 Voranigo method of use 75 2035-12-04
11844758 Voranigo method of use 75 2035-12-04
11345677 Voranigo method of use 75 2039-01-16
11345677 Voranigo method of use 75 2039-01-16
9579324 Voranigo composition of matter 17 2034-07-11
10172864 Voranigo composition of matter 17 2034-07-11
10172864 Voranigo composition of matter 17 2034-07-11
9579324 Voranigo composition of matter 17 2034-07-11

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9579324 Voranigo composition of matter 17 2034-07-11
9579324 Voranigo composition of matter 17 2034-07-11
10172864 Voranigo composition of matter 17 2034-07-11
10172864 Voranigo composition of matter 17 2034-07-11
11345677 Voranigo method of use 75 2039-01-16
11345677 Voranigo method of use 75 2039-01-16
11844758 Voranigo method of use 75 2035-12-04
11844758 Voranigo method of use 75 2035-12-04
12433895 Voranigo method of use 75 2034-07-11
12433895 Voranigo method of use 75 2034-07-11

Related